LANGER BIOMECHANICS GROUP INC
NT 10-K, 1999-06-01
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Previous: PANERA BREAD CO, 10-Q, 1999-06-01
Next: MERIT DIVERSIFIED INTERNATIONAL INC, 10-Q, 1999-06-01



                     U.S. SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING
                         Commission File Number: 0-12991

       [X] Form 10-K and Form 10-KSB     [ ] Form 20-F       [ ] Form 11-K
             [ ] Form 10-Q and Form 10-QSB     [ ] Form N-SAR
                       For Period Ended: February 28, 1999

  [ ]  Transition Report on Form 10-K        [ ]  Transition Report on Form 20-F
  [ ]  Transition Report on Form 11-K        [ ]  Transition Report on Form 10-Q
  [ ]  Transition Report on Form N-SAR
                        For the Transition Period Ended:

- --------------------------------------------------------------------------------

Nothing  in this  form  shall be  construed  to imply  that the  Commission  has
verified any information contained herein.

- --------------------------------------------------------------------------------

If  the  notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
                                 Not applicable

- --------------------------------------------------------------------------------

Part I - Registrant Information

- --------------------------------------------------------------------------------

Full Name of Registrant:                The Langer Biomechanics Group, Inc.
Former Name if applicable:              Not Applicable
Address of Principal Executive Office:  450 Commack Road
                                        Deer Park, New York 11729

- --------------------------------------------------------------------------------

Part II - Rule 12b-25(b) and (c)

- --------------------------------------------------------------------------------

If the subject report could not be filed without  unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate) [X]

     (a)      The reasons  described  in  reasonable  detail in Part III of this
     form could not be eliminated without unreasonable effort or expense;
     (b)      The subject annual report,  semi-annual report,  transition report
     on Form 10-K,  Form 20-F,  11-K or Form N-SAR,  or portion  thereof will be
     filed on or before the fifteenth  calendar day following the prescribed due
     date; or the subject quarterly report or transition report on Form 10-Q, or
     portion thereof will be filed on or before the fifth calendar day following
     the prescribed due date; and
     (c)      The  accountant's  statement  or other  exhibit  required  by Rule
     12b-25(c) has been attached if applicable.

- --------------------------------------------------------------------------------
<PAGE>

Part III - Narrative

- --------------------------------------------------------------------------------

State below in  reasonable  detail the  reasons  why Form 10-K and Form  10-KSB,
20-F,  11-K,  10-Q and Form 10-QSB,  N SAR, or the transition  report or portion
thereof could not be filed within the prescribed period.

The Langer  Biomechanics Group, Inc. (the "Company") does not currently employ a
Chief Financial  Officer or controller.  As a result,  there has been a delay in
the  completion of the Company's  financial  statements.  A new Chief  Financial
Officer is expected to begin employment in mid-June, 1999.

- --------------------------------------------------------------------------------

Part IV - Other Information

- --------------------------------------------------------------------------------

     (1) Name and  telephone  number  of  person  to  contact  in regard to this
notification:

                                Daniel J. Gorney
                                 (516) 667-1200

     (2) Have all other periodic  reports  required under Section 13 or 15(d) of
the Securities  Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940 during the preceding  twelve months or for such shorter  period that the
registrant was required to file such report(s) been filed?  If the answer is no,
identify report(s).

                                [X] Yes       [ ] No

     (3) Is it anticipated that any significant  change in results of operations
from the corresponding  period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?

                                [X] Yes       [ ] No

     If so, attach an explanation of the anticipated  change,  both  narratively
and  quantitatively,  and if  appropriate,  state the reasons  why a  reasonable
estimate of the results cannot be made.

          While the  Company  anticipates  that there will not be a  significant
change in net sales or net income for the fiscal  year ended  February  28, 1999
("Fiscal 1999") from the fiscal year ended February 28, 1998 ("Fiscal 1998"), it
does expect that income from operations will be significantly lower than that of
the  prior  fiscal  year.  This  is due in  part to  balance  sheet  adjustments
associated with the  installation of new computer system.  In addition,  general
and  administrative  costs  increased  in Fiscal  1999 over  Fiscal  1998 due to
severance  payments  to the former  Chief  Executive  Officer  and the  expenses
associated with recruiting a replacement.

- --------------------------------------------------------------------------------

     The Langer Biomechanics Group, Inc. has  caused  this  notification  to  be
signed on its behalf by the undersigned thereunto duly authorized.



                                       THE LANGER BIOMECHANICS GROUP, INC.

Date: June 1, 1999                 By:    /s/ Daniel J. Gorney
                                       -------------------------------------
                                         Daniel J. Gorney
                                         Chief Executive Officer and Presidnet



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission